Brief: Biosergen Q3 EBITDA Loss Narrows To SEK 4.3 Mln
08/11/2024 07:35
Nov 8 (Reuters) - Biosergen AB BIOSGN.ST :
* Q3 EBITDA LOSS SEK 4,3 MILLION VERSUS LOSS SEK 7.5 MILLION
YEAR
AGO
* Q3 NET LOSS SEK 4,3 MILLION VERSUS LOSS SEK 7,5 MILLION
YEAR AGO
Source text: ID:nWkrVZq45
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million